Regenerative Medicine Market Size, Share & Trends Report

Regenerative Medicine Market Size, Share & Trends Analysis Report By Product (Cell-based Immunotherapies, Gene Therapies), By Therapeutic Category, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-952-4
  • Number of Pages: 230
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2023
  • Industry: Healthcare

Market Segmentation

  • Regenerative Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Therapeutics
      • Primary cell-based therapeutics
        • Dermatology
        • Musculoskeletal
        • Surgical
        • Dental
        • Others
      • Stem Cell & Progenitor Cell-based therapeutics
        • Autologous
        • Allogenic
        • Others
      • Cell-based Immunotherapies
      • Gene Therapies
    • Tools
    • Banks
    • Services
  • Regenerative Medicine Therapeutic Category Outlook (Revenue, USD Million, 2018 - 2030 )
    • Dermatology
    • Musculoskeletal
    • Immunology & Inflammation
    • Oncology
    • Cardiovascular
    • Ophthalmology
    • Others
  • Regenerative Medicine Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Regenerative Medicine Market, By Product (USD Million)
        • Therapeutics
          • Primary cell-based therapeutics
            • Dermatology
            • Musculoskeletal
            • Surgical
            • Dental
            • Others
          • Stem Cell & Progenitor Cell-based therapeutics
            • Autologous
            • Allogenic
            • Others
          • Cell-based Immunotherapies
          • Gene Therapies
        • Tools
        • Banks
        • Services
      • North America Regenerative Medicine Market, By Therapeutic Category (USD Million)
        • Dermatology
        • Musculoskeletal
        • Immunology & Inflammation
        • Oncology
        • Cardiovascular
        • Ophthalmology
        • Others
      • U.S.
        • U.S. Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • U.S. Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Canada
        • Canada Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Canada Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
    • Europe
      • Europe Regenerative Medicine Market, By Product (USD Million)
        • Therapeutics
          • Primary cell-based therapeutics
            • Dermatology
            • Musculoskeletal
            • Surgical
            • Dental
            • Others
          • Stem Cell & Progenitor Cell-based therapeutics
            • Autologous
            • Allogenic
            • Others
          • Cell-based Immunotherapies
          • Gene Therapies
        • Tools
        • Banks
        • Services
      • Europe Regenerative Medicine Market, By Therapeutic Category (USD Million)
        • Dermatology
        • Musculoskeletal
        • Immunology & Inflammation
        • Oncology
        • Cardiovascular
        • Ophthalmology
        • Others
      • UK
        • UK Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • UK Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Germany
        • Germany Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Germany Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • France
        • France Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • France Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Italy
        • Italy Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Italy Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Spain
        • Spain Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Spain Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Denmark
        • Denmark Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Denmark Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Norway
        • Norway Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Norway Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Sweden
        • Sweden Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Sweden Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
    • Asia Pacific
      • Asia Pacific Regenerative Medicine Market, By Product (USD Million)
        • Therapeutics
          • Primary cell-based therapeutics
            • Dermatology
            • Musculoskeletal
            • Surgical
            • Dental
            • Others
          • Stem Cell & Progenitor Cell-based therapeutics
            • Autologous
            • Allogenic
            • Others
          • Cell-based Immunotherapies
          • Gene Therapies
        • Tools
        • Banks
        • Services
      • Asia Pacific Regenerative Medicine Market, By Therapeutic Category (USD Million)
        • Dermatology
        • Musculoskeletal
        • Immunology & Inflammation
        • Oncology
        • Cardiovascular
        • Ophthalmology
        • Others
      • Japan
        • Japan Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Japan Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • China
        • China Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • China Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • India
        • India Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • India Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • South Korea
        • South Korea Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • South Korea Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Thailand
        • Thailand Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Thailand Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
    • Latin America
      • Latin America Regenerative Medicine Market, By Product (USD Million)
        • Therapeutics
          • Primary cell-based therapeutics
            • Dermatology
            • Musculoskeletal
            • Surgical
            • Dental
            • Others
          • Stem Cell & Progenitor Cell-based therapeutics
            • Autologous
            • Allogenic
            • Others
          • Cell-based Immunotherapies
          • Gene Therapies
        • Tools
        • Banks
        • Services
      • Latin America Regenerative Medicine Market, By Therapeutic Category (USD Million)
        • Dermatology
        • Musculoskeletal
        • Immunology & Inflammation
        • Oncology
        • Cardiovascular
        • Ophthalmology
        • Others
      • Brazil
        • Brazil Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Brazil Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Mexico
        • Mexico Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Mexico Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Argentina
        • Argentina Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Argentina Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
    • MEA
      • MEA Regenerative Medicine Market, By Product (USD Million)
        • Therapeutics
          • Primary cell-based therapeutics
            • Dermatology
            • Musculoskeletal
            • Surgical
            • Dental
            • Others
          • Stem Cell & Progenitor Cell-based therapeutics
            • Autologous
            • Allogenic
            • Others
          • Cell-based Immunotherapies
          • Gene Therapies
        • Tools
        • Banks
        • Services
      • MEA Regenerative Medicine Market, By Therapeutic Category (USD Million)
        • Dermatology
        • Musculoskeletal
        • Immunology & Inflammation
        • Oncology
        • Cardiovascular
        • Ophthalmology
        • Others
      • South Africa
        • South Africa Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • South Africa Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Saudi Arabia
        • Saudi Arabia Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Saudi Arabia Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • UAE
        • UAE Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • UAE Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others
      • Kuwait
        • Kuwait Regenerative Medicine Market, By Product (USD Million)
          • Therapeutics
            • Primary cell-based therapeutics
              • Dermatology
              • Musculoskeletal
              • Surgical
              • Dental
              • Others
            • Stem Cell & Progenitor Cell-based therapeutics
              • Autologous
              • Allogenic
              • Others
            • Cell-based Immunotherapies
            • Gene Therapies
          • Tools
          • Banks
          • Services
        • Kuwait Regenerative Medicine Market, By Therapeutic Category (USD Million)
          • Dermatology
          • Musculoskeletal
          • Immunology & Inflammation
          • Oncology
          • Cardiovascular
          • Ophthalmology
          • Others

Regenerative Medicine Market Dynamics

Drivers: Presence Of A Strong Pipeline And Increasing Number Of Clinical Trials

A robust investigational pipeline is a significant investment in the high potential of new products in the future. In addition, the presence of a strong pipeline is one of the major drivers in the regenerative medicine market. Companies invest heavily in research & development to upgrade their products with the latest technology and fulfill the unmet needs of patients. A strong pipeline expands the growth potential of the company. Due to easy access to data through genomic, proteomic, and Electronic Health Record (EHR) databases, numerous companies are investigating various cell-based therapies to aid in the treatment of previously untreatable conditions. Furthermore, the growing demand for robust therapies to address the rising cancer prevalence is contributing to growth in clinical trial numbers. In 2022, the maximum percent of all clinical trials, as shown in the below figure, were based in oncology, particularly in leukemia, lymphoma, and cancers of the breast, cervix, bladder, colon, esophagus, ovaries, brain, pancreas, and others. Around 700 companies are currently working on developing cell-based therapies for various diseases. This is anticipated to increase the competition among companies to create a specific and efficient pipeline.

High Economic Impact Of Regenerative Medicine

The growing burden of chronic diseases is significantly increasing healthcare expenditure across the globe. About 25% of the total healthcare expenditure is generated from around 1% of the diseases. Demographic trends, such as the rising geriatric population, are expected to double over the coming two decades. These trends are projected to have a major impact on healthcare expenses. For instance, in the U.S., the population aged over 65 years is expected to rise by 8% from 2010 to 2030. This unprecedented demographic shift is expected to increase the pressure on the healthcare system. One of the approaches to reduce the pressure on the healthcare system is developing an effective alternative treatment for diseases that cost the most. These include stroke & cardiovascular diseases, neurodegenerative disorders, and diabetes. Furthermore, regenerative medicines have been identified to have the unique ability to alter the fundamental mechanisms of diseases. Regenerative therapies in trials provide promising solutions for specific chronic indications with unmet medical needs. These solutions involve using different products and approaches, including tissue-engineered products, gene therapy, biologics, small molecules, allogeneic & autologous stem cells, and combinational products that show promising therapeutic applications. Combined efforts from government, biotechnology & pharmaceutical companies, private investors, and healthcare providers are anticipated to impact market growth significantly.

Restraints: High Treatment Costs

Regenerative medicines are often highly personalized, which makes it difficult to manufacture and evaluate their safety, cost-effectiveness, & efficacy. Hence, the cost of treatment increases, restraining market growth. Furthermore, stringent regulations and high operational costs are raising entry barriers for this market. As manufacturing costs increase, the cost of these novel therapies and medicines surges. In addition, the time required for developing therapeutics based on regenerative medicines is more than conventional medicines. Consequently, the cost incurred in developing products in both generations is anticipated to increase the treatment cost. In addition, according to DVC stem, the average stem cell therapy cost can range between USD 5000 and USD 50,000. Similarly, several newly launched gene therapies can incur significant treatment costs for the patients. For instance, Luxturna launched with a cost of USD 425,000 per eye, and Zolgensma launched with a price of USD 2.12 million. Hence, the high cost of the therapies might restrict market growth.

What Does This Report Include?

This section will provide insights into the contents included in this regenerative medicine market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Regenerative medicine market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Regenerative medicine market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon